Developing therapeutic vaccines against Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Developing therapeutic vaccines against Alzheimer's disease.

Developing therapeutic vaccines against Alzheimer's disease.

http://www.wikidata.org/entity/Q38636151

about

Early Signs of Pathological Cognitive Aging in Mice Lacking High-Affinity Nicotinic Receptors.The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine.Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Alzheimer's disease: experimental models and reality.The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis.Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer's disease.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.

P2860

Q27323221-683767D2-5B0D-46EE-A89E-4A30898B4EB1 Q33692255-46DA261B-BF12-444F-8E36-CE4D16C41DAB Q37473219-A2FCDF75-FC88-4073-9091-6373364529CF Q37584887-135CD964-2C64-4E54-8EC7-1F68B1170C13 Q37630548-01AF9332-8C89-44A3-A731-301AB67DC289 Q39057135-20FF31E3-F611-4215-BAB1-A236D31DAFDB Q41043719-36E53ABB-B55E-40CF-BC5E-BA09FA3B7794 Q41548991-9212E11B-6AFB-48B7-B32F-6FB7C1E55450 Q41938119-45E2DA8A-F41A-439E-840D-20CA87FF3692 Q42286450-C9974F60-BBCD-4A64-960E-D21FD55349C6 Q42655652-657A26D0-2CDF-4E9E-8472-C6B9A269C522 Q47833979-911578BD-F3A1-427D-A923-B24187F382BD Q53397797-943A8DCA-AA35-4163-9BBD-66A6F9C3D8D1 Q55365163-A3852491-0ED4-4F25-8375-DF99FC2FEB1C

P2860

Developing therapeutic vaccines against Alzheimer's disease.

http://www.wikidata.org/entity/Q38636151

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Developing therapeutic vaccines against Alzheimer's disease.

@en

type

label

Developing therapeutic vaccines against Alzheimer's disease.

@en

prefLabel

Developing therapeutic vaccines against Alzheimer's disease.

@en

P1433

Q38636151-AA719463-34DC-468E-A27F-15486E6DA760

P1476

Q38636151-1CC34812-632F-4EE1-BECC-4D7236F6E6DF

P2860

Q38636151-0521EBB8-5CE9-40B2-9D83-306FE57B64DF

Q38636151-082331F3-CA6C-46AE-B171-EB5C0C2D6F4B

Q38636151-099EABBD-3C0A-4363-903F-9C4408C019BD

Q38636151-0AFADF26-6353-414E-8DFA-CE478C00EF88

Q38636151-113D26B7-BE87-4972-8B24-30D44ED34F6D

Q38636151-11E52A7A-4DAB-43AD-98C3-E9783A0DA70D

Q38636151-152956CA-58DF-43FC-BA2D-076E42B15C7B

Q38636151-153FF42A-5BE3-4328-9B8C-99D3E8AE025D

Q38636151-18B54BEB-21C8-4314-BAEF-7EBC3426FFB4

Q38636151-1A7A1CD6-34E7-4F96-BB23-CEC00D99870D

P304

Q38636151-E334654E-F9E8-4AFF-B547-DF3591AEA694

P31

Q38636151-12153A96-9C5E-4070-A4F4-BF996A6852C3

P356

Q38636151-591890A1-8907-4092-A1C9-1334CBC4EC31

P433

Q38636151-8F1E57E9-635D-4553-B661-71FA5CF4E149

P478

Q38636151-8D54996D-CB08-458A-8A36-6286124C1CA1

P50

Q38636151-C1D303C3-F244-4DA3-B767-7AD93F9343D9

Q38636151-E3FD5976-B22C-4E50-9A36-AF94F0D98380

P577

Q38636151-B2F43D70-8C5C-405A-B0C4-84EA9113849C

P698

Q38636151-19FE679C-869F-4DF5-98C7-46D0068BF000

P921

Q38636151-64EBE35D-549C-4AD2-8E56-128836548874

P932

Q38636151-CE3E3319-6865-4C19-BDC4-EB45752BAFE1

P356

14760584.2016.1121815

P1433

Expert Review of Vaccines

P1476

Developing therapeutic vaccines against Alzheimer's disease.

@en

P2860

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide

A stop-codon mutation in the BRI gene associated with familial British dementia

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy

Transmission and spreading of tauopathy in transgenic mouse brain

Clearance systems in the brain-implications for Alzheimer disease

Immunotherapy for Alzheimer's disease: hoops and hurdles

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

How do immune cells support and shape the brain in health, disease, and aging?

Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms

Innate immunity in the CNS: redefining the relationship between the CNS and Its environment

P304

401-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2016.1121815

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Eleanor Drummond

Thomas Wisniewski

P577

2015-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26577574

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4940858

http://www.w3.org/2001/XMLSchema#string